Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Bracing and Reconstruction of the Anterior Cruciate Ligament for Efficacy Trial

NCT: NCT06942754 · RECRUITING

NCT IDNCT06942754
StatusRECRUITING
Start Date2025-09-11
Completion2028-12

Brief Summary

Several attempts have been made to reduce these failure rates and improve return to sports rates in high-risk populations, and one of these approaches has been postoperative bracing. A recent survey of the Anterior cruciate ligament (ACL) Study Group has shown that 53% of surgeons prefers functional bracing following ACL reconstruction. Currently, however, there is no clear consensus on whether functional bracing following ACL reconstruction leads to lower failure rates, improved stability or better patient-reported outcomes when compared to ACL reconstruction without bracing.

Frequently Asked Questions

What is Bracing and Reconstruction of the Anterior Cruciate Ligament for Efficacy Trial?

Bracing and Reconstruction of the Anterior Cruciate Ligament for Efficacy Trial is a clinical trial registered under NCT06942754. Current status: RECRUITING.

What is the status of NCT06942754?

The current status of NCT06942754 (Bracing and Reconstruction of the Anterior Cruciate Ligament for Efficacy Trial) is: RECRUITING.

When did Bracing and Reconstruction of the Anterior Cruciate Ligament for Efficacy Trial start?

Bracing and Reconstruction of the Anterior Cruciate Ligament for Efficacy Trial started on 2025-09-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑